Shawn E.

Shawn E. is an accomplished Executive Key Account Manager with extensive experience in the rare disease and orphan drug sectors, currently leading institutional key account initiatives at UCB since March 2020. Prior roles include Senior Key Account Manager at Zogenix, where Shawn played a key role in hospital and Center of Excellence leadership, and Account Manager at Greenwich Biosciences, contributing to significant orphan drug launches. Shawn has consistently achieved high performance recognition, including multiple Presidents Circle Awards for commercial excellence. Earlier career experiences span over a decade in various roles at Mallinckrodt Pharmaceuticals and Bayer Pharmaceuticals, focusing on autoimmune and rare diseases, where Shawn notably transformed underperforming regions into top-tier markets. Educational qualifications include a master's degree from Cornell University and an MBA from the University of Phoenix, alongside a BA from San Diego State University.